Table 2.
African American | Chinese American | Hispanic American | Non-Hispanic white American | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Characteristics | Tertile 1 | Tertile 2 | Tertile 3 | p Value | Tertile 1 | Tertile 2 | Tertile 3 | p Value | Tertile 1 | Tertile 2 | Tertile 3 | p Value | Tertile 1 | Tertile 2 | Tertile 3 | p Value |
HGF Range (pg/mL) | 342.6–813.9 | 814.3–999.6 | 1000.0–2151.8 | 292.4–738.3 | 738.3–892.1 | 892.4–2135.9 | 317.7–903.2 | 903.7–1112.9 | 1113.4–2094.1 | 313.6–783.5 | 783.6–993.1 | 993.2–2117.0 | ||||
Age, years | 59.1 (9.3) | 62.3 (9.9) | 65.0 (10.0) | <0.001 | 57.9 (9.5) | 62.6 (9.3) | 66.6 (10.3) | <0.001 | 58.0 (9.4) | 61.3 (9.9) | 64.3 (10.7) | <0.001 | 59.3 (9.5) | 62.6 (10.1) | 65.9 (10.1) | <0.001 |
Sex, % female | 50 | 61 | 55 | 0.39 | 52 | 48 | 54 | 0.64 | 49 | 52 | 55 | 0.08 | 47 | 52 | 57 | <0.001 |
Body Mass Index, kg/m2 | 29.3 (5.3) | 30.4 (5.9) | 30.7 (6.2) | <0.001 | 23.2 (2.9) | 24.2 (3.3) | 24.5 (3.6) | <0.001 | 28.2 (4.5) | 29.2 (4.6) | 30.9 (5.7) | <0.001 | 26.4 (4.3) | 27.6 (4.9) | 29.2 (5.5) | <0.001 |
Education | <0.001 | <0.001 | 0.33 | <0.001 | ||||||||||||
≤11th grade | 9 | 11 | 15 | 16 | 26 | 33 | 39 | 50 | 46 | 3 | 5 | 7 | ||||
High school graduate | 16 | 19 | 23 | 12 | 18 | 19 | 21 | 18 | 23 | 14 | 15 | 22 | ||||
Some college | 35 | 34 | 36 | 25 | 16 | 19 | 30 | 22 | 24 | 23 | 29 | 33 | ||||
Bachelor’s degree | 21 | 19 | 13 | 28 | 22 | 18 | 5 | 7 | 5 | 27 | 23 | 17 | ||||
Graduate/professional school | 20 | 17 | 13 | 20 | 18 | 11 | 6 | 4 | 3 | 33 | 29 | 20 | ||||
Income | 0.002 | 0.08 | 0.10 | <0.001 | ||||||||||||
< $25,000 | 22 | 32 | 37 | 41 | 49 | 60 | 44 | 50 | 55 | 11 | 14 | 23 | ||||
$25,000 – $50,000 | 31 | 32 | 34 | 22 | 21 | 23 | 35 | 33 | 31 | 23 | 26 | 32 | ||||
$50,000 – $100,000 | 37 | 27 | 23 | 24 | 19 | 12 | 19 | 15 | 12 | 33 | 35 | 30 | ||||
≥ $100,000 | 10 | 9 | 6 | 13 | 11 | 6 | 3 | 3 | 2 | 33 | 25 | 15 | ||||
Systolic Blood Pressure, mmHg | 128.4 (20.0) | 131.6 (22.2) | 135.2 (22.1) | 0.01 | 118.6 (18.8) | 125.6 (21.7) | 129.8 (22.7) | 0.02 | 121.0 (19.4) | 126.9 (21.2) | 131.8 (23.2) | <0.001 | 119.3 (18.7) | 122.7 (19.9) | 128.4 (21.7) | <0.001 |
Hypertension, % Yes | 49 | 59 | 70 | <0.001 | 25 | 38 | 49 | 0.001 | 30 | 41 | 53 | <0.001 | 29 | 36 | 50 | <0.001 |
Diabetes Mellitus, % Yes | 11 | 17 | 24 | <0.001 | 6 | 13 | 20 | <0.001 | 8 | 19 | 25 | <0.001 | 2 | 5 | 11 | <0.001 |
Total Cholesterol, mg/dL | 190.0 (35.6) | 192.8 (36.8) | 186.0 (35.6) | <0.001 | 194.0 (32.8) | 190.1 (32.0) | 194.1 (30.5) | 0.47 | 202.4 (38.0) | 200.9 (37.9) | 191.6 (35.5) | <0.001 | 195.3 (33.3) | 197.3 (36.1) | 194.9 (35.8) | 0.31 |
HDL Cholesterol, mg/dL | 54.1 (15.4) | 52.3 (15.4) | 50.8 (14.7) | <0.001 | 51.3 (13.7) | 49.1 (11.8) | 48.1 (12.3) | <0.001 | 49.2 (13.9) | 47.4 (12.9) | 46.4 (12.2) | <0.001 | 54.2 (16.7) | 52.2 (15.4) | 50.4 (14.7) | <0.001 |
Triglycerides, mg/dL | 97.2 (75.2) | 107.3 (70.3) | 109.9 (59.5) | <0.001 | 133.0 (83.7) | 135.3 (72.2) | 160.5 (94.9) | <0.001 | 155.6 (111.6) | 162.4 (109.2) | 154.5 (80.9) | 0.82 | 117.8 (69.4) | 133.6 (105.1) | 147.3 (90.6) | <0.001 |
Creatinine, mg/dL | 1.0 (0.2) | 1.0 (0.2) | 1.0 (0.3) | <0.001 | 0.9 (0.2) | 0.9 (0.2) | 0.9 (0.3) | 0.03 | 0.9 (0.2) | 0.9 (0.2) | 0.9 (0.4) | 0.68 | 0.9 (0.2) | 1.0 (0.2) | 1.0 (0.2) | <0.001 |
Glomerular Filtration Rate (GFR) | 88.4 (17.0) | 85.9 (18.5) | 84.8 (21.7) | 0.43 | 85.2 (14.1) | 83.0 (16.4) | 78.7 (18.5) | 0.3 | 83.6 (15.8) | 83.9 (17.4) | 82.7 (21.0) | 0.005 | 78.3 (20.4) | 75.6 (13.8) | 73.8 (15.9) | 0.15 |
Current Smoker, % Yes | 13 | 17 | 23 | <0.001 | 3 | 6 | 8 | <0.001 | 9 | 14 | 18 | <0.001 | 8 | 11 | 15 | <0.001 |
Current Use of Alcohol, % Yes | 52 | 51 | 46 | 0.58 | 34 | 32 | 28 | 0.45 | 51 | 49 | 43 | 0.56 | 76 | 73 | 66 | <0.001 |
Antilipidemic Therapy, % Yes | 15 | 16 | 19 | 0.91 | 9 | 14 | 20 | 0.02 | 12 | 13 | 14 | 0.22 | 15 | 18 | 22 | 0.008 |
Statin Use, % Yes | 14 | 15 | 18 | 0.89 | 9 | 12 | 17 | 0.4 | 11 | 12 | 13 | 0.25 | 14 | 16 | 20 | 0.05 |
Hypertension Medication Use, % Yes | 40 | 49 | 62 | <0.001 | 18 | 28 | 40 | <0.001 | 24 | 31 | 42 | <0.001 | 24 | 33 | 42 | <0.001 |
Calcium Channel Blockers, % Yes | 18 | 17 | 28 | 0.005 | 5 | 10 | 14 | 0.03 | 9 | 9 | 14 | 0.03 | 6 | 6 | 11 | 0.01 |
Angiotensin Type 2 Antagonists | 4 | 3 | 5 | 0.36 | 3 | 4 | 9 | 0.07 | 1 | 3 | 4 | 0.02 | 2 | 2 | 4 | 0.1 |
Aspirin Use, % Yes | 29 | 30 | 33 | 0.51 | 10 | 21 | 24 | 0.03 | 23 | 26 | 30 | 0.61 | 35 | 41 | 42 | 0.55 |
Diabetes Medication Use, % Yes | 80 | 74 | 83 | 0.31 | 67 | 79 | 72 | 0.85 | 66 | 84 | 82 | 0.12 | 47 | 70 | 75 | 0.26 |
Diuretic Use, % Yes | 18 | 21 | 26 | 0.17 | 2 | 5 | 6 | 0.004 | 5 | 8 | 12 | 0.004 | 7 | 12 | 21 | <0.001 |
Females Only | ||||||||||||||||
Hormone Replacement Therapy, % Yes | 55 | 45 | 40 | 0.004 | 44 | 31 | 28 | 0.09 | 45 | 41 | 34 | 0.76 | 68 | 69 | 57 | <0.001 |
Post-menopause, % Yes | 82 | 85 | 87 | 0.65 | 78 | 85 | 94 | 0.55 | 82 | 90 | 90 | 0.95 | 79 | 85 | 90 | 0.33 |
GFR, glomerular filtration rate; HDL, high-density lipoproteins; HGF, hepatocyte growth factor.
p Values from a linear regression model adjusted for age and sex.